Obidoxime Antagonizes the Neuromuscular Failure Induced by Neostigmine and Diisopropyl Fluorophosphate via Different Mechanisms.

[1]  J. Tattersall.  Ion channel blockade by oximes and recovery of diaphragm muscle from soman poisoning in vitro , 1993, British journal of pharmacology.

[2]  B. Melchers,et al.  On the mechanism of spontaneous recovery of neuromuscular transmission after acetylcholinesterase inhibition in the rat neuromuscular junction , 1991, Brain Research.

[3]  E. Albuquerque,et al.  Effectiveness of oximes 2-PAM and HI-6 in recovery of muscle function depressed by organophosphate agents in the rat hemidiaphragm: an in vitro study. , 1991, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[4]  B. Melchers,et al.  On the mechanism whereby HI-6 improves neuromuscular function after oxime-resistant acetylcholinesterase inhibition and subsequent impairment of neuromuscular transmission. , 1991, European journal of pharmacology.

[5]  S. Hong,et al.  Antagonism by tubocurarine and verapamil of the regenerative acetylcholine release from mouse motor nerve. , 1989, European journal of pharmacology.

[6]  S.J. Hong,et al.  Reversals of the neostigmine‐induced tetanic fade and endplate potential run‐down with respect to the autoregulation of transmitter release , 1988, British journal of pharmacology.

[7]  E. Albuquerque,et al.  Acetylcholinesterase reactivators modify the functional properties of the nicotinic acetylcholine receptor ion channel. , 1988, The Journal of pharmacology and experimental therapeutics.

[8]  J. Valdés,et al.  Desensitization of the nicotinic acetylcholine receptor by diisopropylfluorophosphate. , 1988, Journal of biochemical toxicology.

[9]  J. Clement,et al.  Comparison of serum concentrations of the acetylcholinesterase oxime reactivators HI-6, obidoxime, and PAM to efficacy against sarin (isopropyl methylphosphonofluoridate) poisoning in rats. , 1987, Toxicology and applied pharmacology.

[10]  S. Hong,et al.  A regenerating release of acetylcholine from mouse motor nerve terminals treated with anticholinesterase agents , 1986, Neuroscience Letters.

[11]  S.J. Hong,et al.  Mechanisms of the inhibition by neostigmine of tetanic contraction in the mouse diaphragm , 1986, British journal of pharmacology.

[12]  J. Valdés,et al.  Competitive binding of the oximes HI-6 and 2-PAM with regional brain muscarinic receptors. , 1985, Biochemical pharmacology.

[13]  Chong Ma,et al.  Quantitative Structure-Activity Relationships and Possible Mechanisms of Action of Bispyridinium Oximes as Antidotes Against Pinacolyl Methylphosphonofluoridate , 1983 .

[14]  D. Wilson.  Influence of presynaptic receptors on neuromuscular transmission in rat. , 1982, The American journal of physiology.

[15]  R. Ellin.  Anomalies in theories and therapy of intoxication by potent organophosphorus anticholinesterase compounds. , 1982, General pharmacology.

[16]  O. Wolthuis,et al.  Analysis of oxime-induced neuromuscular recovery in guinea pig, rat and man following soman poisoning in vitro. , 1981, European journal of pharmacology.

[17]  J. Clement.  Toxicology and pharmacology of bispyridium oximes--insight into the mechanism of action vs Soman poisoning in vivo. , 1981, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[18]  S. Sterri,et al.  Effect of toxogonin and P2S on the toxicity of carbamates and organophosphorus compounds. , 2009, Acta pharmacologica et toxicologica.

[19]  P. Lundy,et al.  Ganglion blocking properties of some bispyridinium soman antagonists. , 1979, European journal of pharmacology.

[20]  J. Clement.  Pharmacological actions of HS-6, an oxime, on the neuromuscular junction. , 1979, European journal of pharmacology.

[21]  F. Hobbiger.  Pharmacology of Anticholinesterase Drugs , 1976 .

[22]  E. Albuquerque,et al.  A study of the irreversible cholinesterase inhibitor, diisopropylfluorophosphate, on time course of end-plate currents in frog sartorius muscle. , 1974, The Journal of pharmacology and experimental therapeutics.

[23]  B. Reiff,et al.  Effect of oximes on the acute toxicity of anticholinesterase carbamates. , 1973, Toxicology and applied pharmacology.

[24]  R. Lancaster.  Relationships between in vivo and in vitro inhibition of acetylcholinesterase (AChE) and impairment of neuromuscular transmission in the rat phrenic-nerve diaphragm by a tertiary anticholinesterase and its quaternary analogue. , 1973, Biochemical pharmacology.

[25]  O. Wolthuis,et al.  The spontaneous recovery of respiration and neuromuscular transmission in the rat after anticholinesterase poisoning. , 1968, European journal of pharmacology.

[26]  F. Hobbiger,et al.  The reactivating and antidotal actions of n,n'-trimethylenebis (pyridinium-4-aldoxime) (TMB-4) and n,n'-oxydimethylenebis (pyridinum-4-aldoxime) (toxogonin), with particular reference to their effect on phosphorylated acetylcholinesterase in the brain , 1966 .

[27]  J. H. Fleisher,et al.  Effects of 2-PAM and TMB-4 on neuromuscular transmission. , 1965, The Journal of pharmacology and experimental therapeutics.

[28]  C. van der Meer,et al.  The effect of oximes on isolated organs intoxicated with organophosphorus anticholinesterases. , 1965, Biochemical pharmacology.

[29]  K. Ikeda,et al.  EFFECTS OF 2-PAM AND SUCCINYLCHOLINE ON NEUROMUSCULAR TRANSMISSION IN THE FROG , 1962 .

[30]  P. Sadler,et al.  Protection against lethal organophosphate poisoning by quaternary pyridine aldoximes. , 1959, British journal of pharmacology and chemotherapy.

[31]  J. Barnes,et al.  The role of cholinesterase at the myoneural junction. , 1953, British journal of pharmacology and chemotherapy.